<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders - Gu, Y - 2015 | Cochrane Library</title> <meta content="Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders - Gu, Y - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011577.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders - Gu, Y - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011577.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011577.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders" name="citation_title"/> <meta content="Yisu Gu" name="citation_author"/> <meta content="NHS/ University of Oxford" name="citation_author_institution"/> <meta content="Lise J Estcourt" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="lise.estcourt@nhsbt.nhs.uk" name="citation_author_email"/> <meta content="Carolyn Doree" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="Sally Hopewell" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Paresh Vyas" name="citation_author"/> <meta content="University of Oxford and Oxford University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD011577.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/10/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011577.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011577.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011577.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anemia, Aplastic [therapy]; Anemia, Refractory [therapy]; Bone Marrow Diseases [*therapy]; Clinical Protocols; Erythrocyte Transfusion [*methods]; Leukemia, Myelomonocytic, Chronic [therapy]; Myelodysplastic Syndromes [therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011577.pub2&amp;doi=10.1002/14651858.CD011577.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="fw9sVDQH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011577\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011577\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011577.pub2",title:"Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders",firstPublishedDate:"Oct 5, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Haematological Malignancies Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=fw9sVDQH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011577.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011577.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011577.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011577.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011577.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011577.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011577.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011577.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011577.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011577.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1493 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011577.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0091"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-sec-0085"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/appendices#CD011577-sec-0096"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/table_n/CD011577StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/table_n/CD011577StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#CD011577-cr-0002">Yisu Gu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#CD011577-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Lise J Estcourt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#CD011577-cr-0004">Carolyn Doree</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#CD011577-cr-0005">Sally Hopewell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information#CD011577-cr-0006">Paresh Vyas</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information/en#CD011577-sec-0101">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 October 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011577.pub2">https://doi.org/10.1002/14651858.CD011577.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011577-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011577-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011577-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011577-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011577-abs-0001" lang="en"> <section id="CD011577-sec-0001"> <h3 class="title" id="CD011577-sec-0001">Background</h3> <p>Bone marrow failure disorders include a heterogenous group of disorders, of which myelodysplastic syndrome (MDS), forms the largest subgroup. MDS is predominantly a disease of the elderly, with many elderly people managed conservatively with regular allogeneic red blood cell (RBC) transfusions to treat their anaemia. However, RBC transfusions are not without risk. Despite regular transfusions playing a central role in treating such patients, the optimal RBC transfusion strategy (restrictive versus liberal) is currently unclear. </p> </section> <section id="CD011577-sec-0002"> <h3 class="title" id="CD011577-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of a restrictive versus liberal red blood cell transfusion strategy for patients with myelodysplasia, acquired aplastic anaemia, and other inherited bone marrow failure disorders. </p> </section> <section id="CD011577-sec-0003"> <h3 class="title" id="CD011577-sec-0003">Search methods</h3> <p>We searched for randomised controlled trials (RCTs) in the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2015, Issue 4), Ovid MEDLINE (from 1946), Ovid EMBASE (from 1974), EBSCO CINAHL (from 1937), the Transfusion Evidence Library (from 1980) and ongoing trial databases to 26th May 2015. </p> </section> <section id="CD011577-sec-0004"> <h3 class="title" id="CD011577-sec-0004">Selection criteria</h3> <p>RCTs including patients with long‐term bone marrow failure disorders that require allogeneic blood transfusion, who are not being actively treated with a haematopoietic stem cell transplant, or intensive chemotherapy. </p> </section> <section id="CD011577-sec-0005"> <h3 class="title" id="CD011577-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane review methodology. One author initially screened all references, and excluded any that were clearly irrelevant or duplicates. Two authors then independently screened all abstracts of articles, identified by the review search strategy, for relevancy. Two authors independently assessed the full text of all potentially relevant articles for eligibility, completed the data extraction and assessed the studies for risk of bias using The Cochrane Collaboration’s ’Risk of bias’ tool. </p> </section> <section id="CD011577-sec-0006"> <h3 class="title" id="CD011577-sec-0006">Main results</h3> <p>We included one trial (13 participants) and identified three ongoing trials that assess RBC transfusion strategies in people with MDS. </p> <p>The quality of the evidence was very low across different outcomes according to GRADE methodology. </p> <p>The one included study randomised participants to a restrictive [haemoglobin (Hb) transfusion trigger &lt; 72 g/L, 8 participants] or liberal [Hb trigger &lt; 96 g/L, 5 participants] transfusion policy. There was insufficient evidence to determine a difference in all‐cause mortality (1 RCT; 13 participants; RR 0.13, 95% CI 0.01 to 2.32; very low quality evidence). There was insufficient evidence to determine a difference in the number of red blood cell transfusions (1 RCT; 13 participants; 1.8 units per patient per month in the liberal group, compared to 0.8 in the restrictive arm, no standard deviation was reported; very low quality evidence). There were no anaemia‐related complications reported (cardiac failure) and no reported effect on activity levels (no statistics provided). The study did not report: mortality due to bleeding/infection/transfusion reactions or iron overload, quality of life, frequency and length of hospital admissions, serious infections (requiring admission to hospital), or serious bleeding (e.g. WHO/CTCAE grade 3 (or equivalent) or above). </p> </section> <section id="CD011577-sec-0007"> <h3 class="title" id="CD011577-sec-0007">Authors' conclusions</h3> <p>This review indicates that there is currently a lack of evidence for the recommendation of a particular transfusion strategy for bone marrow failure patients undergoing supportive treatment only. The one RCT included in this review was only published as an abstract and contained only 13 participants. Further randomised trials with robust methodology are required to develop the optimal transfusion strategy for such patients, particularly as the incidence of the main group of bone marrow failure disorders, MDS, rises with an ageing population. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011577-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011577-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011577-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011577-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011577-abs-0004">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011577-abs-0003" lang="en"> <h3>The optimum transfusion strategy for anaemic patients with bone marrow failure disorders receiving supportive treatment </h3> <p><b>Review Question</b> </p> <p>A restrictive transfusion policy involves giving a red blood cell transfusion if the oxygen‐carrying capacity of blood (haemoglobin) falls below a certain level. A liberal transfusion policy involves giving a red blood cell transfusion at a higher haemoglobin level. </p> <p>This review aims to assess whether a restrictive or liberal transfusion policy is superior in terms of death (due to any cause), death due to bleeding, infection, transfusion reactions or iron overload, quality of life, frequency and length of hospital admissions, serious bleeding or infections, and number of red blood cell transfusions required. </p> <p><b>Background</b> </p> <p>The bone marrow is where many types of blood cells are produced. Red blood cells are necessary to bring oxygen to all parts of the body, white blood cells fight against infection, and platelets in the blood help to form clots and prevent bleeding. Bone marrow failure can have different causes and can happen at birth or later in life, and may result in too few of any or all of the three types of blood cells in the body. Too few red blood cells causes a low haemoglobin level, called anaemia, which may result in poor delivery of oxygen to the body. This can cause shortness of breath, tiredness and has a significant impact on quality of life. </p> <p>Regular red blood cell transfusions are used to support patients and improve their quality of life when treatments that might cure the condition are not an option. However, there are certain risks involved with regular use of red blood cell transfusions, for example, transfusion reactions, transfusion‐transmitted infections and iron overload. </p> <p>Currently it is not clear if the best transfusion policy is a restrictive or liberal one. </p> <p><b>Study Characteristics</b> </p> <p>Only one small study including 13 patients with bone marrow failure was included in this review. The study was funded by two government agencies and one charity. We are aware of three ongoing studies which have not yet been completed. </p> <p>The evidence is current to 26th May 2015.</p> <p><b>Key Results</b> </p> <p>The one included study was too small to demonstrate any difference in all‐cause mortality (death due to any cause) or number of red cell transfusions received between a restrictive compared to a liberal red blood cell transfusion policy. At the current time, there is a lack of evidence to recommend a restrictive transfusion strategy over a liberal one. Trials with good methodology are needed to determine the best transfusion policy for patients with long ‐term bone marrow failure disorders. </p> <p><b>Quality of the Evidence</b> </p> <p>The evidence for the findings was of very low quality. This was because very small numbers of participants were included in the study. Only 13 patients were recruited to the trial rather than the planned 200 participants due to problems with recruitment. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011577-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011577-sec-0091"></div> <h3 class="title" id="CD011577-sec-0092">Implications for practice</h3> <section id="CD011577-sec-0092"> <p>The results of this systematic review indicate that there is currently very limited evidence available to recommend a particular transfusion strategy for patients with bone marrow failure requiring supportive treatment. The only data available are extracted from one RCT. This trial recruited very small numbers of patients (13 participants) and it is currently not possible to recommend one transfusion strategy over another for the supportive management of patients with bone marrow failure. </p> </section> <h3 class="title" id="CD011577-sec-0093">Implications for research</h3> <section id="CD011577-sec-0093"> <p>As the incidence of MDS rises with an ageing population, many of whom are unable to tolerate curative therapy, further clinical trials with robust methodology are now required to develop the optimal transfusion strategy for such people. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011577-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011577-sec-0015"></div> <div class="table" id="CD011577-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Restrictive red blood cell transfusion compared with liberal red blood cell transfusion for patients with myelodysplastic syndrome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with myelodysplastic syndrome </p> <p><b>Settings</b>: 2 General and 1 University Hospital </p> <p><b>Intervention:</b> Restrictive red blood cell transfusion policy (Hb trigger &lt; 72 g/L) </p> <p><b>Comparison:</b> Liberal red blood cell transfusion policy (Hb trigger &lt; 96 g/L) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>[Liberal]</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>[Restrictive]</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><b>All cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><b>RR 0.13</b> (0.01 to 2.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>13<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b> <br/> (1 to 162) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> <br/> (2 to 348) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>260 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> <br/> (3 to 603) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality secondary to bleeding/infection/transfusion reactions or iron overload</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Frequency and length of hospital admissions</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious infections (requiring admission to hospital)</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious bleeding (e.g. WHO/CTCAE grade 3 (or equivalent) or above )</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Red blood cell transfusion requirements</b> </p> <p>(units of red blood cells per patient per month)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study reported a lower total transfused red cell amount in the restrictive versus liberal arm (0.8 units red cells per patient per month versus 1.8 units per patient per month). </p> <p>No statistical analysis of significance or further information was available from the study authors. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 for imprecision, very small study with only 13 participants. </p> <p><sup>2</sup>Downgraded by 2 for risk of bias due to reporting bias, attrition bias, and other bias. </p> <p><sup>3</sup>The mortality data was based on data derived from a Kaplan Meier plot for the IPSS‐R low, intermediate and high risk groups. Using information at one year from diagnosis (<a href="./references#CD011577-bbs2-0026" title="deSwartL , SmithA , JohnstonTW , HaaseD , DrosteJ , FenauxP , et al. Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry. British Journal of Haematology2015;[ahead of print online publication]:doi: 10.1111/bjh.13450. ">de Swart 2015</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011577-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011577-sec-0016"></div> <p>Please see <a href="#CD011577-sec-0106">Published notes</a> for an explanation of some technical terms. </p> <section id="CD011577-sec-0017"> <h3 class="title" id="CD011577-sec-0017">Description of the condition</h3> <p>The bone marrow is the site of production of red cells, white cells and platelets from stem cells (termed collectively as haematopoiesis). Bone marrow failure disorders encompass a wide range of diseases that cause quantitative (reduced numbers) or qualitative (reduced function) defects of red cells, white cells and platelets. </p> <p>Clinical symptoms of patients with bone marrow failure disorders are related to the underlying cytopenias (anaemia, neutropenia and thrombocytopenia) that arise from this ineffective haematopoiesis. Patients can present with fatigue and shortness of breath due to anaemia, recurrent infections due to neutropenia and bleeding or bruising due to thrombocytopenia. The chronic and often severe nature of the anaemia results in the majority of patients eventually requiring regular red blood cell transfusions, if they cannot tolerate or are ineligible for curative therapy, or if they have refractory disease (disease not responsive to curative therapy) (<a href="./references#CD011577-bbs2-0031" title="GoldbergSL , ChenE , CorralM , GuoA , Mody‐PatelN , PecoraAL , et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. Journal of Clinical Oncology2010;28(17):2847‐52. ">Goldberg 2010</a>; <a href="./references#CD011577-bbs2-0067" title="YoungNS , KaufmanDW . The epidemiology of acquired aplastic anemia. Haematologica2008;93(4):489‐92. ">Young 2008</a>). </p> <p>Bone marrow failure disorders can be classified according to the underlying pathophysiology, into three broad categories: myelodysplastic syndrome (MDS), acquired aplastic anaemia, and inherited bone marrow failure disorders. </p> <p>MDS encompasses a diverse group of disorders that are characterised by dysplasia in one or more cell lines (blood cells have an abnormal shape or size), ineffective haematopoiesis, and an increased risk of developing acute myeloid leukaemia (AML). Overall the incidence of MDS is estimated at between 2.3 to 4.5 per 100,000 per year (<a href="./references#CD011577-bbs2-0028" title="DinmohamedAG , VisserO , VanNordenY , HuijgensPC , SonneveldP , Van deLoosdrechtAA , et al. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population‐based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010. European Journal of Cancer2014;50(5):1004‐12. ">Dinmohamed 2014</a>; <a href="./references#CD011577-bbs2-0043" title="MaX , DoesM , RazaA , MayneST . Myelodysplastic syndromes: incidence and survival in the United States. Cancer2007;109(8):1536‐42. ">Ma 2007</a>; <a href="./references#CD011577-bbs2-0044" title="MaX . Epidemiology of myelodysplastic syndromes. American Journal of Medicine2012;125(7 Supp):S2‐5. ">Ma 2012</a>; <a href="./references#CD011577-bbs2-0050" title="NeukirchenJ , SchoonenWM , StruppC , GattermannN , AulC , HaasR , et al. Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS‐registry. Leukemia Research2011;35(12):1591‐6. ">Neukirchen 2011</a>). However, the incidence increases markedly with age, with the highest incidence in those aged over 80 years (&gt; 30 per 100,000 per year) (<a href="./references#CD011577-bbs2-0028" title="DinmohamedAG , VisserO , VanNordenY , HuijgensPC , SonneveldP , Van deLoosdrechtAA , et al. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population‐based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010. European Journal of Cancer2014;50(5):1004‐12. ">Dinmohamed 2014</a>; <a href="./references#CD011577-bbs2-0043" title="MaX , DoesM , RazaA , MayneST . Myelodysplastic syndromes: incidence and survival in the United States. Cancer2007;109(8):1536‐42. ">Ma 2007</a>; <a href="./references#CD011577-bbs2-0044" title="MaX . Epidemiology of myelodysplastic syndromes. American Journal of Medicine2012;125(7 Supp):S2‐5. ">Ma 2012</a>; <a href="./references#CD011577-bbs2-0050" title="NeukirchenJ , SchoonenWM , StruppC , GattermannN , AulC , HaasR , et al. Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS‐registry. Leukemia Research2011;35(12):1591‐6. ">Neukirchen 2011</a>). The International Prognostic Scoring System (IPSS) and the Revised IPSS (IPSS‐R) are used to predict the prognosis of patients with MDS at diagnosis (<a href="./references#CD011577-bbs2-0032" title="GreenbergPL , TuechlerH , SchanzJ , SanzG , Garcia‐ManeroG , SoleF , et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood2012;120:2454–65. ">Greenberg 2012</a>). Management recommendations for patients with MDS have largely been based on their IPSS score (<a href="./references#CD011577-bbs2-0040" title="KillickSB , CarterC , CulliganD , DalleyC , Das‐GuptaE , DrummondM , et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology2014;164(4):503‐25. ">Killick 2014</a>). ‘Low‐risk’ MDS includes patients with IPSS Low/Intermediate‐1 (INT‐1), and ‘high‐risk’ MDS includes those with IPSS Intermediate‐2 (INT‐2)/High (<a href="./references#CD011577-bbs2-0040" title="KillickSB , CarterC , CulliganD , DalleyC , Das‐GuptaE , DrummondM , et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology2014;164(4):503‐25. ">Killick 2014</a>). </p> <p>Acquired aplastic anaemia is a disease that results in a hypocellular bone marrow with quantitative defects of all three cell lines. The incidence in Europe and North America is two per million population per year (<a href="./references#CD011577-bbs2-0038" title="IssaragrisilS , KaufmanD , AndersonT , ChansungK , LeavertonP , ShapiroS , et al. The epidemiology of aplastic anaemia in Thailand. Blood2006;107:1299–1307. ">Issaragrisil 2006</a>; <a href="./references#CD011577-bbs2-0047" title="MontanéE , Ibánëz , L , VidalX , BallarinE , PigR , GarciaN , et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica2008;93:518‐23. ">Montané 2008</a>), whereas the incidence in Asia is higher, with estimates ranging from 3.9 to 7.4 per million per year (<a href="./references#CD011577-bbs2-0067" title="YoungNS , KaufmanDW . The epidemiology of acquired aplastic anemia. Haematologica2008;93(4):489‐92. ">Young 2008</a>). The underlying cause is unknown in most cases, but certain industrial chemicals (<a href="./references#CD011577-bbs2-0067" title="YoungNS , KaufmanDW . The epidemiology of acquired aplastic anemia. Haematologica2008;93(4):489‐92. ">Young 2008</a>), agricultural pesticides (<a href="./references#CD011577-bbs2-0038" title="IssaragrisilS , KaufmanD , AndersonT , ChansungK , LeavertonP , ShapiroS , et al. The epidemiology of aplastic anaemia in Thailand. Blood2006;107:1299–1307. ">Issaragrisil 2006</a>; <a href="./references#CD011577-bbs2-0048" title="MuirKR , ChilversCED , HarrissC , CoulsonL , GraingeM , DarbyshireP , et al. The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation. British Journal of Haematology2003;123:906‐14. ">Muir 2003</a>), drugs (<a href="./references#CD011577-bbs2-0038" title="IssaragrisilS , KaufmanD , AndersonT , ChansungK , LeavertonP , ShapiroS , et al. The epidemiology of aplastic anaemia in Thailand. Blood2006;107:1299–1307. ">Issaragrisil 2006</a>; <a href="./references#CD011577-bbs2-0067" title="YoungNS , KaufmanDW . The epidemiology of acquired aplastic anemia. Haematologica2008;93(4):489‐92. ">Young 2008</a>), and hepatitis viruses (<a href="./references#CD011577-bbs2-0054" title="RauffB , IdreesM , ShahSA , ButtS , ButtAM , AliL , et al. Hepatitis associated aplastic anemia: a review. Virology Journal2011;28:87. ">Rauff 2011</a>) have been reported to cause aplastic anaemia. Treatment is tailored to the individual needs of the patient, but involves a combination of supportive care for pancytopenia (red cell and platelet transfusions, prophylactic antimicrobials), immunosuppressive therapy, and bone marrow transplant. </p> <p>Inherited bone marrow failure disorders include the ‘classical’ bone marrow failure disorders associated normally with a global haematopoietic defect (Fanconi anaemia), Dyskeratosis congenita, Shwachman‐Diamond syndrome, Pearson syndrome, and familial aplastic anaemia (both X‐linked and autosomal forms), as well as those associated with a single lineage haematopoietic defect resulting in anaemia, the most common being Diamond‐Blackfan anaemia (<a href="./references#CD011577-bbs2-0029" title="DokalI , VulliamyT . Inherited aplastic anaemias/bone marrow failure syndromes. Blood Reviews2008;22(3):141‐53. [DOI: 10.1016/j.blre.2007.11.003] ">Dokal 2008</a>). The most common of these, Fanconi anaemia, has a reported incidence of approximately one in 360,000 live births, with a carrier frequency of one in 300 (<a href="./references#CD011577-bbs2-0030" title="GiriN . The inherited bone marrow failure syndromes. Haematologia2004;8:57‐9. ">Giri 2004</a>). Haematopoietic stem cell transplant forms the definitive treatment in many of these disorders, but supportive therapy in terms of red cell and platelet transfusions are often needed for symptomatic relief, either prior to transplant, or for those patients not suitable to undergo transplant. </p> </section> <section id="CD011577-sec-0018"> <h3 class="title" id="CD011577-sec-0018">Description of the intervention</h3> <p>Red blood cell transfusions play a central role in the supportive management of patients with long‐term bone marrow failure disorders. Currently, there are no clear national guidelines in the UK or elsewhere for the recommendation of a particular transfusion strategy, restrictive (giving a red blood cell transfusion if the haemoglobin (Hb) falls below a certain low threshold) or liberal (giving a red blood cell transfusion at a higher Hb threshold), for such patients. </p> <p>The use of a restrictive transfusion policy is supported by the results of a recent systematic review of 19 randomised controlled trials (RCTs) (<a href="./references#CD011577-bbs2-0025" title="CarsonJL , CarlessPA , HebertPC . Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3] ">Carson 2012</a>). This systematic review included RCTs of both medical and surgical patients of all ages (excluding neonates), but did not include patients with long‐term bone marrow failure disorder. <a href="./references#CD011577-bbs2-0025" title="CarsonJL , CarlessPA , HebertPC . Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3] ">Carson 2012</a> showed that a restrictive transfusion strategy significantly reduced the risk of receiving a transfusion by 39% (risk ratio (RR) 0.61, 95% CI 0.52 to 0.72), without a negative impact on the rate of adverse events (including mortality, myocardial infarction, stroke, pneumonia and thromboembolism). The transfusional requirements and outcomes of the patients included within <a href="./references#CD011577-bbs2-0025" title="CarsonJL , CarlessPA , HebertPC . Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3] ">Carson 2012</a> may differ from patients with bone marrow failure disorders, and it is therefore less clear whether a restrictive strategy would be beneficial in patients with long‐term cytopenias. </p> <p>Patients with bone marrow failure disorders often present with bi‐ or tri‐lineage cytopenia. There is therefore some concern that concurrent anaemia with thrombocytopenia may increase the risk of bleeding (<a href="./references#CD011577-bbs2-0062" title="ValeriCR , KhuriS , RagnoG . Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma‐clotting proteins. Transfusion2007;47(4 Supp):206S‐48S. ">Valeri 2007</a>). A pilot RCT (60 patients with acute leukaemia or receiving a haematopoietic stem cell transplantation (HSCT), studied the effects of haemoglobin concentration on bleeding risk. It compared those transfused at a haemoglobin threshold of less than 80 g/L to those transfused at a haemoglobin trigger of less than 120 g/L (<a href="./references#CD011577-bbs2-0064" title="WebertKE , CookRJ , CoubanS , CarruthersJ , LeeKA , BlajchmanMA , et al. A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion2008;48(1):81‐91. ">Webert 2008</a>). This small feasibility study, (conducted to assess whether a larger definitive study would be possible) did not demonstrate a difference in clinically significant bleeding between the study arms, but this may be because the study was not designed to detect a difference. The planned larger definitive study has not yet been performed. The <a href="./references#CD011577-bbs2-0064" title="WebertKE , CookRJ , CoubanS , CarruthersJ , LeeKA , BlajchmanMA , et al. A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion2008;48(1):81‐91. ">Webert 2008</a> RCT is included in an ongoing systematic review examining the transfusion needs of patients with haematological malignancies receiving intensive chemotherapy, with or without haematopoietic stem cell transplantation (<a href="./references#CD011577-bbs2-0023" title="ButlerC , TayJ , DoreeC , BrunskillSJ , TrivellaM , FergussonDA , et al. Restrictive versus liberal red blood cell transfusion strategies for patients with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD011305] ">Butler 2014</a>). </p> </section> <section id="CD011577-sec-0019"> <h3 class="title" id="CD011577-sec-0019">How the intervention might work</h3> <p>A restrictive red blood cell transfusion for patients with chronic bone marrow failure, if feasible, may be advantageous for several reasons. Firstly, the risk of alloimmunisation (i.e. the production of antibodies in response to foreign antigens) to leucocytes in red blood cell transfusions due to the production of both human leukocyte antigen and non‐human leukocyte antigen (minor histocompatibility) antibodies may be reduced with a more restrictive transfusion strategy. This may result in a lower risk of graft rejection for those people with aplastic anaemia treated later with an allogeneic bone marrow transplant (<a href="./references#CD011577-bbs2-0039" title="KaminskyER , HowsJM , GoldmanJM , BatchelorJR . Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non‐HLA antigens. British Journal of Haematology1990;76:401‐5. ">Kaminski 1990</a>). Secondly, regular red blood cell transfusion, in the supportive treatment of low‐risk MDS, results in raised serum ferritin, which together with transfusion dependence, act as independent adverse risk factors for survival in this group of people (<a href="./references#CD011577-bbs2-0045" title="MalcovatiL , PortaMG , PascuttoC , InvernizziR , BoniM , TravaglinoE , et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. Journal of Clinical Oncology2005;23:7594‐603. ">Malcovati 2005</a>). Indeed, serum ferritin levels &gt; 2500 µg/L are associated with an increased transplant‐related mortality in those patients with high‐risk MDS undergoing myeloablative stem cell transplant (<a href="./references#CD011577-bbs2-0020" title="ArmandP , KimHT , RhodesJ , SainvilMM , CutlerC , HoVT , et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biology of Blood and Marrow Transplantation2011;17(6):852‐60. ">Armand 2011</a>). Thirdly, a restrictive transfusion strategy may also be beneficial when considering the risks of transfusion‐transmitted infections, which although very low in the UK (as a result of robust screening programmes), are still a significant problem in those countries with particularly high rates of HIV transmission. This is because there is a time‐lag between a person becoming infected with HIV and the HIV test being positive (the window period can be three to six months if only an antibody test is used) (<a href="./references#CD011577-bbs2-0065" title="World Health Organization. Screening donated blood for transfusion‐transmissible infections: recommendations. WHO Publications2009. ">WHO 2009</a>), the inability to test blood due to resource issues (<a href="./references#CD011577-bbs2-0066" title="World Health Organization. Blood safety and availability. Fact sheet N°279Reviewed June 2015; Vol. http://www.who.int/mediacentre/factsheets/fs279/en/# [Accessed 1st September 2015]. ">WHO 2015</a>), and ineffective screening of donors (<a href="./references#CD011577-bbs2-0066" title="World Health Organization. Blood safety and availability. Fact sheet N°279Reviewed June 2015; Vol. http://www.who.int/mediacentre/factsheets/fs279/en/# [Accessed 1st September 2015]. ">WHO 2015</a>). </p> <p>One further aspect to consider regarding the success of a restrictive versus liberal transfusion programme is the effect on the quality of life in this group of people, data for which are limited. A prospective multicentre trial of 36 elderly low‐ and intermediate‐risk MDS sufferers, treated to a target haemoglobin of &gt; 120 g/L with either erythropoietin (with the addition of Granulocyte‐colony stimulating factor (GCSF) if no response) or red blood cell transfusion, showed an improvement in quality of life in terms of fatigue, dyspnoea, constipation and social functioning (<a href="./references#CD011577-bbs2-0051" title="Nilsson‐EhleH , BirgegårdG , SamuelssonJ , AntunovicP , AstermarkJ , GareliusH , et al. Quality of life, physical function and MRI T2* in elderly low‐risk MDS patients treated to a haemoglobin level of =120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions. European Journal of Haematology2011;87:244‐52. ">Nilsson‐Ehle 2011</a>). </p> <p>In the older population, particularly, where aggressive treatment may be inappropriate, a more supportive approach with regular red blood cell transfusions, primarily for symptomatic relief, may be an attractive alternative for many people with chronic marrow failure disorders. </p> <p>This forms the basis of this systematic review, which aims to compare the effects of a liberal versus restrictive red blood cell transfusion programme in those patients undergoing supportive, rather than active treatment for bone marrow failure, with a particular focus on its impact on quality of life. </p> </section> <section id="CD011577-sec-0020"> <h3 class="title" id="CD011577-sec-0020">Why it is important to do this review</h3> <p>Currently, no clear transfusion strategies are recommended in national guidelines for people with bone marrow failure disorders (<a href="./references#CD011577-bbs2-0019" title="Anonymous . RBC Concentrates. Transfusion Medicine and Hemotherapy2009;36(6):362‐70. ">Anonymous 2009</a>; <a href="./references#CD011577-bbs2-0040" title="KillickSB , CarterC , CulliganD , DalleyC , Das‐GuptaE , DrummondM , et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology2014;164(4):503‐25. ">Killick 2014</a>; <a href="./references#CD011577-bbs2-0049" title="National Blood Authority. Module 3 Medical. Patient Blood Management Guidelines. Canberra, Australia: National Blood Authority, 2012. ">NBA 2012</a> ). As such, many patients are transfused following local hospital policies, or transfused according to individual patient circumstances, which may result in under‐ or over‐transfusion. Studies of other patient groups, specifically those in critical care and those with acute upper gastrointestinal bleeding have shown possible improved outcomes in terms of survival within the restrictive transfusion arm (<a href="./references#CD011577-bbs2-0037" title="HébertPC , WellsG , BlajchmanMA , MarshallJ , MartinC , PagliarelloG , et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New England Journal of Medicine1999;340:409‐17. ">Hébert 1999</a>; <a href="./references#CD011577-bbs2-0063" title="VillanuevaC , ColomoA , BoschA , ConcepcionM , Hernandez‐GeaV , AracilC , et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine2013;368(1):11‐21. ">Villanueva 2013</a>). </p> <p>A restrictive transfusion policy with a lower haemoglobin threshold may be attractive for people who are regularly transfused for several reasons. Despite the very low risks of viral transmission of HIV, hepatitis B and C in the UK, such blood‐borne viruses remain considerably higher in other parts of the world. In addition, less frequent red blood cell transfusions would also reduce the number of non‐infective adverse events. In 2012, according to the UK Serious Hazards of Transfusion (SHOT) reporting system, haemolytic transfusion reactions were responsible for 19%, and transfusion‐related circulatory overload (TACO) for 13% of all pathological transfusion reactions (<a href="./references#CD011577-bbs2-0022" title="Bolton‐MaggsPHB . Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012. Transfusion Medicine2013;23:217‐8. ">Bolton‐Maggs 2013</a>). Death or severe morbidity occurred in 43% of all cases of TACO reported to SHOT (<a href="./references#CD011577-bbs2-0022" title="Bolton‐MaggsPHB . Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012. Transfusion Medicine2013;23:217‐8. ">Bolton‐Maggs 2013</a>). However, a transfusion policy that is too restrictive may leave the patient with harmful levels of anaemia, with potential adverse effects on myocardial remodelling and the subsequent development of cardiovascular disease (<a href="./references#CD011577-bbs2-0053" title="PereiraAA , SarnakMJ . Anemia as a risk factor for cardiovascular disease. Kidney International2003;64(87):S32‐9. ">Pereira 2003</a>). Therefore, a greater understanding of the safety and benefits of a liberal versus restrictive transfusion policy in patients with bone marrow failure disorders enables the provision of a more tailored red blood cell transfusion strategy for such patients. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011577-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011577-sec-0021"></div> <p>To assess the efficacy and safety of a restrictive versus liberal red blood cell transfusion strategy for patients with myelodysplasia, acquired aplastic anaemia, and other inherited bone marrow failure disorders. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011577-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011577-sec-0022"></div> <section id="CD011577-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011577-sec-0024"> <h4 class="title">Types of studies</h4> <p>This review included only randomised controlled trials (RCTs), irrespective of language or publication status. </p> </section> <section id="CD011577-sec-0025"> <h4 class="title">Types of participants</h4> <p>We included all people, irrespective of age, with long‐term bone marrow failure disorders that require allogeneic blood transfusion, who are not being actively treated with a haematopoietic stem cell transplant, or intensive chemotherapy. </p> </section> <section id="CD011577-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We included all allogeneic red blood cell transfusion strategies defined as 'restrictive' and 'liberal'. For individual studies, the restrictive intervention group included people who received an allogeneic red blood cell transfusion only below a definite ‘trigger’ or ‘threshold’ haemoglobin. The liberal control group included people that received an allogeneic red blood cell transfusion based on a more generous transfusion strategy, whereby transfusion usually occurs at a higher haemoglobin. </p> </section> <section id="CD011577-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD011577-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011577-list-0001"> <li> <p>All‐cause mortality</p> </li> </ul> <ul id="CD011577-list-0002"> <li> <p>Mortality due to bleeding, infection, transfusion reactions, or iron overload, or both. </p> </li> </ul> </p> </section> <section id="CD011577-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011577-list-0003"> <li> <p>Frequency and length of hospital admissions</p> </li> </ul> <ul id="CD011577-list-0004"> <li> <p>Frequency and length of intensive care admission</p> </li> </ul> <ul id="CD011577-list-0005"> <li> <p>Quality of life (measured using validated scales, for example, EQ‐5D, FACT‐AN, and EORTC‐30) </p> </li> </ul> <ul id="CD011577-list-0006"> <li> <p>Non‐fatal serious adverse events classified as:</p> </li> </ul> <ul class="plain" id="CD011577-list-0007"> <li> <ul id="CD011577-list-0008"> <li> <p>serious bleeding (e.g. WHO/CTCAE (The Common Terminology Criteria for Adverse Events) grade 3 (or equivalent) or above); </p> </li> <li> <p>adverse transfusion reactions (including, but not limited to transfusion‐related acute lung injury (TRALI), transfusion‐associated circulatory overload (TACO), blood‐group A, B or O incompatibility and transfusion transmitted infection (TTI)); </p> </li> <li> <p>iron overload (defined by ferritin &gt; 1000 and/or clinical symptoms and/or signs of iron overload); and </p> </li> <li> <p>serious infections (infections requiring admission to hospital).</p> </li> </ul> </li> </ul> <ul id="CD011577-list-0009"> <li> <p>Blood product requirement</p> </li> </ul> <ul class="plain" id="CD011577-list-0010"> <li> <ul id="CD011577-list-0011"> <li> <p>Red cell transfusion requirements (for example, number of units required or number of transfusion episodes) and intervals </p> </li> <li> <p>Platelet transfusion requirements (for example, number of pools required, or number of transfusion episodes) and intervals </p> </li> </ul> </li> </ul> <ul id="CD011577-list-0012"> <li> <p>Usage of iron chelation therapy</p> </li> </ul> </p> </section> </section> </section> <section id="CD011577-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <p>The Systematic Review Initiative’s Information Specialist (CD) formulated the search strategies in collaboration with the Cochrane Haematological Malignancies Group. </p> <section id="CD011577-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched for RCTs in the following databases.</p> <p> <ul id="CD011577-list-0013"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2015, Issue 4) (<a href="./appendices#CD011577-sec-0097">Appendix 1</a>) </p> </li> <li> <p>Ovid MEDLINE (1946 to 26th May 2015) (<a href="./appendices#CD011577-sec-0098">Appendix 2</a>) </p> </li> <li> <p>Ovid EMBASE (1974 to 26th May 2015) (<a href="./appendices#CD011577-sec-0099">Appendix 3</a>) </p> </li> <li> <p>EBSCO CINAHL (1937 to 26th May 2015)</p> </li> <li> <p>PubMed (epublications only)</p> </li> <li> <p>Transfusion Evidence Library (www.transfusionevidencelibrary.com) (1980 to 26th May 2015) </p> </li> <li> <p>LILACS (1980 to 26th May 2015)</p> </li> <li> <p>IndMed (1986 to 26th May 2015)</p> </li> <li> <p>PakMediNet (1995 to 26th May 2015)</p> </li> <li> <p>KoreaMed (1958 to 26th May 2015)</p> </li> <li> <p>Web of Science: Conference Proceedings Citation Index‐Science (CPCI‐S) (1990 to 26th May 2015) </p> </li> </ul> </p> <p>We searched for ongoing RCTs to 26th May 2015 in the following databases.</p> <p> <ul id="CD011577-list-0014"> <li> <p>ClinicalTrials.gov</p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (ICTRP)</p> </li> </ul> </p> <p>We combined searches in MEDLINE with the Cochrane RCT highly sensitive search filter, as detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011577-bbs2-0042" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We combined searches in EMBASE and CINAHL with the relevant trial filters developed by the Scottish Intercollegiate Guidelines Network (<a href="./references#CD011577-bbs2-0058" title="Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random Accessed 26 May 2015. ">SIGN 2010</a>). We did not limit searches by year of publication, language or publication status. </p> </section> <section id="CD011577-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We also performed handsearches of the reference lists of included studies in order to identify further relevant studies. We made contact with lead authors of relevant studies to identify any unpublished material, missing data or information regarding ongoing studies. </p> </section> </section> <section id="CD011577-sec-0033"> <h3 class="title" id="CD011577-sec-0033">Data collection and analysis</h3> <section id="CD011577-sec-0034"> <h4 class="title">Selection of studies</h4> <p>We selected studies according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011577-bbs2-0033" title="HigginsJPT , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). The Systematic Review Initiative’s Information Specialist (CD) screened all search hits for relevance against the eligibility criteria and discarded all those that were clearly irrelevant. Thereafter, two authors (YG, LE) independently screened all the remaining references for relevance against the full eligibility criteria. Full text articles were retrieved for all references for which a decision on eligibility could not be made from title and abstract alone. Study design features were assessed against the inclusion criteria. Additional information was requested from study authors as necessary to assess the eligibility for inclusion of individual studies. The two authors discussed the results of study selection and were able to resolve any discrepancies between themselves. The results of study selection was reported using a PRISMA flow diagram (<a href="./references#CD011577-bbs2-0046" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG . Preferred Reporting Items for Systematic Reviews and Meta‐Analyses: The PRISMA Statement. Annals of Internal Medicine2009;151(4):264‐9. ">Moher 2009</a>). </p> </section> <section id="CD011577-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>As recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions,</i> two review authors (YG, LE) independently extracted data onto standardised forms and performed a cross‐check (<a href="./references#CD011577-bbs2-0033" title="HigginsJPT , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). The data extraction form was piloted on two included RCTs. The review authors came to a consensus on the required changes. The review authors were not blinded to names of authors, institutions, journals or the study outcomes. The following information was extracted for each study. </p> <p> <ol id="CD011577-list-0015"> <li> <p>Source: study identification (ID); report ID; review author ID; date of extraction; ID of author checking extracted data; citation of paper; contact authors details. </p> </li> <li> <p>General study information: publication type; study objectives; funding source; conflict of interest declared; other relevant study publication reviewed. </p> </li> <li> <p>Study details and methods: location; country; setting; number of centres; total study duration; recruitment dates; length of follow‐up; power calculation; primary analysis (and definition); stopping rules; method of sequence generation; allocation concealment; blinding (of clinicians, participants and outcome assessors); any concerns regarding bias; inclusion and exclusion criteria; primary outcome(s); secondary outcomes. </p> </li> <li> <p>Characteristics of interventions: number of study arms; description of experimental arm; description of control arm; duration of red cell storage; frequency of minor blood‐group A, B or O mismatched transfusions; other treatments (for example, gamma irradiation of blood products). </p> </li> <li> <p>Characteristics of participants: age; gender; ethnicity; primary diagnosis; subgroup classification of primary disease type where appropriate (for example, World Health Organization (WHO) 2008 classification of MDS (<a href="./references#CD011577-bbs2-0060" title="SwerdlowSH , CampoE , HarrisNL , JaffeES , PileriSA , SteinH , et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Edition. Vol. 2, Lyon: IARC Press, 2008. ">Swerdlow 2008</a>)), severity of primary disease, where appropriate (for example, severe, very severe and non‐severe aplastic anaemia (<a href="./references#CD011577-bbs2-0021" title="BacigalupoA , HowsJM , GluckmanE , NissenC , MarshJ , VanLintMT , et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA) ‐ a report of the EBMT SAA Working Party. British Journal of Haematology1988;70:177‐82. ">Bacigalupo 1988</a>; <a href="./references#CD011577-bbs2-0024" title="CamittaBM , RappeportJM , ParkmanR , NathanDG . Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood1975;45:355–63. ">Camitta 1975</a>)), prognostic classification of primary disease where appropriate (IPSS‐R prognostic scoring system for MDS (<a href="./references#CD011577-bbs2-0032" title="GreenbergPL , TuechlerH , SchanzJ , SanzG , Garcia‐ManeroG , SoleF , et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood2012;120:2454–65. ">Greenberg 2012</a>)); additional therapy received; risk of alloimmunisation; baseline haematology laboratory parameters; cofounders reported. </p> </li> <li> <p>Participant flow: total number screened for inclusion; total number recruited; total number excluded; total number allocated to each study arm; total number analysed (for review outcomes); number of allocated patients who received planned treatment; number of drop‐outs with reasons (percentage in each arm); protocol violations; missing data. </p> </li> <li> <p>Outcomes: all‐cause mortality (undefined and within short‐, medium‐ and long‐term periods); mortality due to infection, bleeding, transfusion reactions or iron overload, or both; non‐fatal serious adverse events (bleeding, adverse transfusion reactions, iron overload and serious infections); number and volume of red blood cell transfusion units received per patient; interval between red blood cell transfusions, number and volume of platelet doses received per patient; interval between platelet transfusion; frequency and duration of hospital admission, frequency and duration of intensive care admission; usage of iron chelation therapy; quality of life. </p> </li> </ol> </p> </section> <section id="CD011577-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed all RCTs for risk of bias using the Cochrane 'Risk of bias' criteria, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011577-bbs2-0034" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). Two review authors (YG, LE) worked independently to assess each element of potential bias listed below as 'high', 'low' or 'unclear' risk of bias. A brief description of the judgement statements upon which the review authors have assessed potential bias is reported in the 'Characteristics of included studies' table. A consensus on the degree of risk of bias was met through comparison of the review author’s statements without the need for consultation with a third author. We did not use the ’Risk of bias’ assessment to explore statistical<br/> heterogeneity in each included study and to perform sensitivity analyses because there was only one included study. We used the Cochrane tool for assessing risk of bias (low, high or unclear risk) in the following areas (<a href="./references#CD011577-bbs2-0035" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011c</a>).<br/> . </p> <p> <ul id="CD011577-list-0016"> <li> <p>Selection bias: (random sequence generation and allocation concealment).</p> </li> <li> <p>Performance bias: (blinding of participants and personnel).</p> </li> <li> <p>Detection bias: (blinding of outcome assessment).</p> </li> <li> <p>Attrition bias: (incomplete outcome data).</p> </li> <li> <p>Reporting bias: (selective reporting).</p> </li> <li> <p>Other bias.</p> </li> </ul> </p> </section> <section id="CD011577-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous outcomes we recorded the mean, standard deviation, and total number of participants in both the treatment and control groups. For dichotomous outcomes we recorded the number of events and the total number of participants in both the treatment and control groups. If data allowed, we undertook quantitative assessments using Review Manager 5 (<a href="./references#CD011577-bbs2-0055" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> <p>We had planned to analyse continuous outcomes using the same scale, using the mean difference (MD) with 95% confidence intervals (CIs), and for continuous outcomes measured with different scales using the standard mean difference (SMD), however no meta‐analyses were performed. We had planned to report hazard ratios (HRs) if available, for mortality data, however no HRs were reported, and we were unable to estimate the HR using the available data and a purpose built method based on the Parmar and Tierney tool (<a href="./references#CD011577-bbs2-0052" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a>; <a href="./references#CD011577-bbs2-0061" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8:16. [DOI: 10.1186/1745‐6215‐8‐16] ">Tierney 2007</a>). </p> <p>We reported risk ratios (RRs) with a 95% CI (for mortality, as HRs were not available). We did not use the Peto Odds Ratio (OR) method for analysis (<a href="./references#CD011577-bbs2-0027" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>) because the number of observed events was not small (&lt; 5% of sample per group). We did not report the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH) with CIs because there was insufficient evidence to determine a difference in any of the reported outcomes. </p> <p>We provided a descriptive summary of the available data when the data could not be presented in any other format. </p> </section> <section id="CD011577-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>We did not encounter any specific unit of analysis issues associated with cluster‐randomised trials, cross‐over studies, and multiple observations for the same outcome. Should any studies of these designs have arisen, we had planned to treat these in accordance with the advice given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011577-bbs2-0036" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in Statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011d</a>). </p> </section> <section id="CD011577-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the authors of the four eligible studies to obtain further information, however no further data could be provided. </p> </section> <section id="CD011577-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We did not perform an assessment of heterogeneity as it was not possible to perform meta‐analysis due to only one study satisfying the eligibility criteria for inclusion. </p> </section> <section id="CD011577-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>We were not able to perform an assessment of reporting bias due to lack of both outcome data and meta‐analysis (<a href="./references#CD011577-bbs2-0041" title="LauJ , IoannidisJP , TerrinN , SchmidCH , OlkinI . The case of the misleading funnel plot. BMJ2006;333(7568):597‐600. ">Lau 2006</a>; <a href="./references#CD011577-bbs2-0059" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). </p> </section> <section id="CD011577-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We performed analyses according to the recommendations of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using aggregated data for analysis (<a href="./references#CD011577-bbs2-0027" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). For statistical analysis, we entered data into Review Manager 5 software (<a href="./references#CD011577-bbs2-0055" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). One review author (YG) entered the data and a second author (LE) then checked for accuracy. Meta‐analysis was not possible because this review included only one study. We therefore provided a descriptive summary of the available information. </p> <section id="CD011577-sec-0043"> <h5 class="title">Summary of findings</h5> <p>We used the GRADE system to build a 'Summary of findings' table, as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011577-bbs2-0056" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011a</a>; <a href="./references#CD011577-bbs2-0057" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). The outcomes we included (comparing a restrictive versus liberal transfusion strategy) are listed below. </p> <p> <ol id="CD011577-list-0017"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Mortality due to bleeding/infection/transfusion reactions or iron overload.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Frequency and length of hospital admissions.</p> </li> <li> <p>Serious bleeding (e.g. WHO/CTCAE grade 3 (or equivalent) or above).</p> </li> <li> <p>Serious infections (requiring admission to hospital).</p> </li> <li> <p>Red blood cell transfusion requirements.</p> </li> </ol> </p> </section> </section> <section id="CD011577-sec-0044"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to conduct the following subgroup analyses.</p> <p> <ul id="CD011577-list-0018"> <li> <p>Subgroup analysis for all bone marrow failure disorders.</p> <ul id="CD011577-list-0019"> <li> <p>Type of bone marrow failure disorders (myelodysplastic syndrome (MDS), aplastic anaemia, congenital bone marrow failure disorder); </p> </li> <li> <p>Paediatric (&lt; 18 years) versus adult (18 to 65 years) versus elderly (&gt; 65 years).</p> </li> </ul> </li> </ul> <ul id="CD011577-list-0020"> <li> <p>Subgroup analysis for individual disorders.</p> <ul id="CD011577-list-0021"> <li> <p>High‐risk MDS versus low‐risk MDS (as defined by IPSS‐R prognostic risk categories/scores);</p> </li> <li> <p>Acquired aplastic anaemia versus inherited childhood bone marrow failure disorder.</p> </li> </ul> </li> </ul> </p> <p>However, subgroup analysis was not possible due to the lack of outcome data.</p> </section> <section id="CD011577-sec-0045"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to assess the robustness of our findings by performing the following sensitivity analyses where appropriate. </p> <p> <ul id="CD011577-list-0022"> <li> <p>Including only those studies with a ‘low risk’ of bias (for example, RCTs with methods assessed as low risk for random sequence generation and concealment of treatment allocation). </p> </li> <li> <p>Including only those studies with less than a 20% drop out rate.</p> </li> </ul> </p> <p>Sensitivity analysis was not possible as no meta‐analysis was performed.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011577-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011577-sec-0046"></div> <section id="CD011577-sec-0047"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD011577-sec-0110" title="">Characteristics of included studies</a>; <a href="./references#CD011577-sec-0111" title="">Characteristics of excluded studies</a>; <a href="./references#CD011577-sec-0112" title="">Characteristics of ongoing studies</a> </p> <section id="CD011577-sec-0048"> <h4 class="title">Results of the search</h4> <p>Please refer to the PRISMA flow diagram (<a href="#CD011577-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD011577-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA Study flow diagram." data-id="CD011577-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA Study flow diagram.</p> </div> </div> </div> <p>The main search was performed on 26th May 2015. A total of 3745 records were identified in the initial search, from which 2286 duplicates were removed, reducing the total records to 1459. From this, one author (CD) screened and removed 346 records that were clearly irrelevant (e.g. non‐human). The remaining 1113 records were screened independently by two authors (YG, LE) against the inclusion criteria, from which 1091 records were excluded as ineligible, often due to incorrect study design or wrong comparisons. The remaining 21 records were obtained as full text articles, from which four studies were excluded as ineligible (two studies included transplant patients only, and two other studies analysed ineligible interventions). There remained a total of four studies eligible for inclusion (one completed and three ongoing studies). </p> </section> <section id="CD011577-sec-0049"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD011577-sec-0110" title="">Characteristics of included studies</a> for full details of the study. Four studies met the inclusion criteria for the review but three of these studies are ongoing (<a href="./references#CD011577-bbs2-0016" title="ISRCTN26088319 . Red cell transfusion and QOL in myelodysplastic syndromes. ISRCTN Registry2014. ">ISRCTN26088319</a>; <a href="./references#CD011577-bbs2-0017" title="NCT02099669 . Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC). CinicalTrials.gov2014. ">NCT02099669</a>; <a href="./references#CD011577-bbs2-0018" title="NTR2684 . Transfusion as supportive care for the improvement of quality of life. Netherlands Trial Register2011. ">NTR2684</a>) so are not eligible for inclusion in this review. </p> <p>One completed study (<a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a>) was included within this review. </p> <section id="CD011577-sec-0050"> <h5 class="title">Study Design</h5> <p>The Temple study (<a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a>) was a parallel‐group multi‐centre (two general and one university hospital), single‐blinded RCT conducted in the Netherlands. This study has only been published as an abstract. The trial ran from July 2002 to June 2004. </p> </section> <section id="CD011577-sec-0051"> <h5 class="title">Setting</h5> <p>The study was conducted in Holland with patients recruited from two general and one university hospital. </p> </section> <section id="CD011577-sec-0052"> <h5 class="title">Participants</h5> <p>The study had originally planned to recruit 200 patients, however due to difficulties in recruitment, only 15 Myelodysplastic syndrome (MDS) patients were included in the study; four were classified as having refractory anaemia, five with refractory anaemia with ringed sideroblasts, four with refractory cytopenia with multilineage dysplasia, one with refractory anaemia with excess of blasts, and one with chronic myelomonocytic leukaemia. From this, 13 patients were randomised to either a restrictive or liberal transfusion policy. </p> </section> <section id="CD011577-sec-0053"> <h5 class="title">Intervention and Comparator</h5> <p>This study compared a restrictive transfusion policy (haemoglobin transfusion trigger &lt; 72 g/L) with a liberal transfusion trigger (haemoglobin &lt; 96 g/L) in terms of red blood cell usage and quality of life. </p> </section> <section id="CD011577-sec-0054"> <h5 class="title">Co‐interventions</h5> <p>There were no co‐interventions in this study.</p> </section> <section id="CD011577-sec-0055"> <h5 class="title">Outcomes</h5> <p>Quality of life was not reported, however there were no anaemia‐related complications (e.g. cardiac failure and cerebrovascular ischaemia) or decrease in activity performance. </p> </section> <section id="CD011577-sec-0056"> <h5 class="title">Funding Sources</h5> <p>The study was funded by two government agencies and one charity.</p> </section> <section id="CD011577-sec-0057"> <h5 class="title">Ongoing Studies</h5> <p>There are three ongoing clinical trials (<a href="./references#CD011577-bbs2-0018" title="NTR2684 . Transfusion as supportive care for the improvement of quality of life. Netherlands Trial Register2011. ">NTR2684</a>, <a href="./references#CD011577-bbs2-0017" title="NCT02099669 . Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC). CinicalTrials.gov2014. ">NCT02099669</a> and <a href="./references#CD011577-bbs2-0016" title="ISRCTN26088319 . Red cell transfusion and QOL in myelodysplastic syndromes. ISRCTN Registry2014. ">ISRCTN26088319</a>). Please see <a href="./references#CD011577-sec-0112" title="">Characteristics of ongoing studies</a> for further details. </p> </section> <section id="CD011577-sec-0058"> <h5 class="title">NTR2684</h5> <p>Trial <a href="./references#CD011577-bbs2-0018" title="NTR2684 . Transfusion as supportive care for the improvement of quality of life. Netherlands Trial Register2011. ">NTR2684</a> is a parallel‐group open‐label RCT that started on 1 January 2011, with a planned closing date of 31 December 2012. However, this study has not been completed and is not actively recruiting participants (e‐mail correspondence with Dr Slomp). This trial is being conducted in the Netherlands. <a href="./references#CD011577-bbs2-0018" title="NTR2684 . Transfusion as supportive care for the improvement of quality of life. Netherlands Trial Register2011. ">NTR2684</a> plans to recruit 100 adults with myelodysplastic syndrome, chronic myelofibrosis and myeloproliferative conditions needing chronic transfusions as supportive care. It will compare transfusion with one unit of packed red blood cells versus two units of packed red blood cells if haemoglobin falls below 5.0mmol/l. </p> </section> <section id="CD011577-sec-0059"> <h5 class="title">NCT02099669</h5> <p>Trial <a href="./references#CD011577-bbs2-0017" title="NCT02099669 . Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC). CinicalTrials.gov2014. ">NCT02099669</a> is a parallel‐group open‐label RCT planned to start in March 2014 with an estimated completion date of February 2016. The trial is running in Canada. <a href="./references#CD011577-bbs2-0017" title="NCT02099669 . Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC). CinicalTrials.gov2014. ">NCT02099669</a> plans to recruit 30 transfusion‐dependent adults with myelodysplastic syndrome. It plans to compare a liberal transfusion strategy (maintaining Hb level between 110 g/L and 120 g/L) versus a restrictive transfusion strategy (maintaining Hb level between 85 g/L and 100 g/L). </p> </section> <section id="CD011577-sec-0060"> <h5 class="title">ISRCTN26088319</h5> <p>Trial <a href="./references#CD011577-bbs2-0016" title="ISRCTN26088319 . Red cell transfusion and QOL in myelodysplastic syndromes. ISRCTN Registry2014. ">ISRCTN26088319</a> is a parallel‐group multicentre RCT conducted in the UK. The trial opened on 10th November 2014, and the recruitment end date is planned for 30th December 2016. <a href="./references#CD011577-bbs2-0016" title="ISRCTN26088319 . Red cell transfusion and QOL in myelodysplastic syndromes. ISRCTN Registry2014. ">ISRCTN26088319</a> plans to recruit 38 transfusion‐dependent adults with myelodysplastic syndrome (to include non‐proliferative chronic myelomonocytic leukaemia (CMML) and other myeloproliferative/myelodysplastic (MPD/MDS) overlap syndromes). It will compare a restrictive transfusion strategy (maintain Hb level between 85 g/L and 100 g/L) versus liberal transfusion strategy (maintain Hb above 100 g/L). </p> </section> </section> <section id="CD011577-sec-0061"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD011577-sec-0111" title="">Characteristics of excluded studies</a> for full details of the studies. </p> <p>A total of 14 full‐text articles were excluded. Of these:</p> <p> <ul id="CD011577-list-0023"> <li> <p>five were review articles (<a href="./references#CD011577-bbs2-0002" title="Balducci , L . Transfusion independence in patients with myelodysplastic syndromes. Impact on outcomes and quality of life. Cancer2006;106(10):2087‐94. ">Balducci 2006</a>; <a href="./references#CD011577-bbs2-0003" title="BennettJ , KouidesP . Diagnosis and management of anaemia in patients with myelodysplastic syndrome. Cancer Control Journal1998;5(Supplement 2):41‐5. ">Bennett 1998</a>; <a href="./references#CD011577-bbs2-0004" title="BowenD . Transfusion management of myelodysplastic syndromes. Transfusion Medicine2010;20(1):S114. ">Bowen 2010</a>; <a href="./references#CD011577-bbs2-0010" title="ListA . Transfusion Independence and and cytogenetic response in myelodysplastic syndromes. What this means for the patient. Heamatologica Reports2006;2:11‐16. ">List 2006</a>; <a href="./references#CD011577-bbs2-0011" title="NeukirchenJ . Iron Chelation in MDS: still a controversial issue. Leukaemia Research2014;38:145‐146. ">Neukirchen 2014</a>) </p> </li> </ul> <ul id="CD011577-list-0024"> <li> <p>five were systematic reviews (<a href="./references#CD011577-bbs2-0005" title="BreretonN , NicklassonL , MuftiG . UK estimates of the burden of disease associated with management of Intermediate‐2 or high‐risk myelodysplastic syndromes. Blood (ASH Annual Meeting Abstracts)2011;118:Abstract 4749. ">Brereton 2011</a>; <a href="./references#CD011577-bbs2-0006" title="CaocciG , EfficaceF , VignettiM , MandelliF , FaziP , LeddaA , et al. Health‐related quality of life of patients with myelodysplastic syndromes ‐ a systematic review from 1980 to 2008. Haematologica (42nd congress of the Italian Society of Haematology, Milan, Italy)2009;94 (s4):111. ">Caocci 2009</a>; <a href="./references#CD011577-bbs2-0008" title="ClissaC , FinelliC , VivoA . The myelodysplastic syndromes: diagnosis, prognosis and therapy. Italian Journal of Medicine2011;5:90‐97. ">Clissa 2011</a>; <a href="./references#CD011577-bbs2-0012" title="PinchonD , StanworthS , DoreeC , BrunskillS , NorfolkD . Quality of life and use of red cell transfusions in patients with myelodysplastic syndromes. A systematic review. American Journal of Haematology2009;84:671‐677. ">Pinchon 2009</a>; <a href="./references#CD011577-bbs2-0013" title="PlatzbeckerU , HofbauerL , EhningerG , HoligK . The clinical, quality of life and economic consequences of chronic anaemia and transfusion support in patients with myelodysplastic syndromes. Leukaemia Research2012;36:525‐536. ">Platzbecker 2012</a>) </p> </li> </ul> <ul id="CD011577-list-0025"> <li> <p>four were RCT's comparing interventions or participants that did not meet our inclusion criteria: </p> </li> </ul> <ul class="plain" id="CD011577-list-0026"> <li> <ul id="CD011577-list-0027"> <li> <p>two only recruited patients undergoing a haematopoietic stem cell transplant (<a href="./references#CD011577-bbs2-0014" title="RobitailleN , LacroixJ , AlexandrovL , ClaytonL , CortierM , et al. Excess of veno‐occlusive disease in a randomised clinical trial on higher trigger for red blood cell transfusion after bone marrow transplantation: a Canadian blood and bone marrow transplant group trial. Biology of Blood and Marrow Transplantion2013;19:468‐473. ">Robitaille 2013</a>; <a href="./references#CD011577-bbs2-0015" title="TayJ , TinmouthA , FergussonD , AllanD . Transfusion of red cell in haematopoietic stem cell transplantation (TRIST): study protocol for a randomised controlled trial. http://trialsjournal.com/content/12/1/207. ">Tay 2011</a>) </p> </li> </ul> </li> </ul> <ul class="plain" id="CD011577-list-0028"> <li> <ul id="CD011577-list-0029"> <li> <p>two compared different interventions that were not relevant to this review (<a href="./references#CD011577-bbs2-0007" title="ChiaJ , SeitelbachM , Chin‐YeeI , HsiaC . Quality of life outcomes of the age of blood in highly transfusion dependent patiens with Myelodysplasia: prospective randomised controlled N‐of‐1 studies. Blood (ASH Annual Meeting Abstracts)2010;116:Abstract 4411. ">Chia 2010</a>; <a href="./references#CD011577-bbs2-0009" title="EfficaceF , SantiniV , LaNasaG , CottoneF , FinelliC , BorinL , et al. Health‐related quality of life in transfusion‐dependent patients with myelodysplastic syndromes treated with deferasirox. A multicentre prospective study. Blood (55th ASH Meeting and Exposition (abstract))2013;122(21):Poster 2980. ">Efficace 2013</a>). </p> </li> </ul> </li> </ul> </p> </section> </section> <section id="CD011577-sec-0062"> <h3 class="title">Risk of bias in included studies</h3> <p>Only one study was included in this review, and it was only published as an abstract, therefore it was not possible to assess risk of bias in the majority of cases due to a lack of information provided in the study abstract. </p> <p>Please see <a href="#CD011577-fig-0002">Figure 2</a> for a visual representation of the risk of bias in the included study. See the <a href="./references#CD011577-sec-0110" title="">Characteristics of included studies</a> section 'Risk of bias' table for further information about the bias identified within the trial. </p> <div class="figure" id="CD011577-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011577-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011577-sec-0063"> <h4 class="title">Allocation</h4> <p>The risk of bias was unclear and could not be assessed due to a lack of information provided by the study abstract. </p> </section> <section id="CD011577-sec-0064"> <h4 class="title">Blinding</h4> <p>There was an unclear risk of performance bias as the patients were blinded to their Hb value during the study period, but the method of blinding and confirmation that blinding had been achieved during the study was not reported. It was also not reported whether clinical staff were blinded to the intervention. </p> <p>The risk of detection bias was unclear and could not be assessed due to lack of information provided by the study abstract. </p> </section> <section id="CD011577-sec-0065"> <h4 class="title">Incomplete outcome data</h4> <p>Losses to follow up were reported in the study abstract. Following randomisation, a total of two patients died in the liberal group, and one patient withdrew consent in the restrictive arm. However, it is not clear if and how these patient data were included in the final analysis of mean Hb, amount of transfused red cells and anaemia related complications. The mean follow up period in the liberal group was 6.2 months (inclusive run in period) and 7.4 months for the restrictive group. Patients were planned to be followed up for 12 months (excluding run in period of three months).The risk of bias was therefore high. </p> </section> <section id="CD011577-sec-0066"> <h4 class="title">Selective reporting</h4> <p>There was evidence of a high risk of reporting bias in this study abstract as a number of primary and secondary outcomes were not reported, despite intention to collect, as described in the trial registration. The following planned outcomes were not reported. </p> <p>Primary outcome measure.</p> <p> <ol id="CD011577-list-0030"> <li> <p>Fatigue.</p> </li> </ol> </p> <p>Secondary outcome measures.</p> <p> <ol id="CD011577-list-0031"> <li> <p>Health Related Quality of Life (HRQoL).</p> </li> <li> <p>Blood usage and the costs.</p> </li> <li> <p>Haemoglobin increase after transfusion.</p> </li> <li> <p>Heart beat, blood pressure, temperature, platelet count.</p> </li> <li> <p>Development of RBC alloantibodies.</p> </li> </ol> </p> </section> <section id="CD011577-sec-0067"> <h4 class="title">Other potential sources of bias</h4> <p>The planned study recruitment for the <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> was 200 patients, however the study was stopped early due to poor recruitment. The numbers of participants in each study arm was very small, with only eight patients in the restrictive arm and five patients in the liberal arm. </p> </section> </section> <section id="CD011577-sec-0068"> <h3 class="title" id="CD011577-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD011577-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD011577-sec-0069"> <h4 class="title">Primary outcomes</h4> <p>We were not able to categorise all outcomes according to short‐, medium‐, and long‐term outcomes due to the limited data available. We were also not able to report the exact definition of these time frames over time periods that were common to as many studies as possible (for example, up to 30 days, one to six months, and greater than six months), again due to limited data. </p> <section id="CD011577-sec-0070"> <h5 class="title">All‐cause mortality</h5> <p>In the <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> study, during the run‐in period of three months when all 15 patients included in the study were transfused with Hb trigger &lt; 96 g/L, there were two patient deaths prior to randomisation. The cause of death was not reported. Post randomisation, two patients out of five allocated to the liberal transfusion policy died. No patient deaths were reported in the restrictive arm. Again, the cause of death was not reported. There was insufficient evidence to determine a difference in all‐cause mortality between a restrictive [haemoglobin (Hb) transfusion trigger &lt; 72 g/L, eight participants] or a liberal [Hb trigger &lt; 96 g/L, five participants] transfusion policy (RR 0.13, 95% CI 0.01 to 2.32; very low quality evidence). (<a href="#CD011577-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD011577-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Liberal versus restrictive, outcome: 1.1 All cause mortality." data-id="CD011577-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Liberal versus restrictive, outcome: 1.1 All cause mortality.</p> </div> </div> </div> </section> <section id="CD011577-sec-0071"> <h5 class="title">Mortality due to bleeding, infection, transfusion reactions, or iron overload</h5> <p>We were unable to report on mortality due to bleeding, infection, transfusion reactions, or iron overload, or both, due to lack of available data. No studies reported this outcome. </p> </section> </section> <section id="CD011577-sec-0072"> <h4 class="title">Secondary outcomes</h4> <p>The only secondary outcome we were able to report on was red blood cell transfusion requirements in terms of number of units required, but not number of transfusion episodes or intervals due to lack of available data. We were not able to report on any of the other secondary outcomes. </p> <section id="CD011577-sec-0073"> <h5 class="title">Frequency and length of hospital admissions</h5> <p>No studies reported this outcome.</p> </section> <section id="CD011577-sec-0074"> <h5 class="title">Frequency and length of intensive care admission</h5> <p>No studies reported this outcome.</p> </section> <section id="CD011577-sec-0075"> <h5 class="title">Quality of life (measured using validated scales, for example, EQ‐5D, FACT‐AN, and EORTC‐30) </h5> <p>No studies reported this outcome.</p> <p>In the <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> study fatigue measured using the Multidimensional Fatigue Index 20 ( MVI20 ) was reported as the primary outcome measure in the clinical trial register for this study. The Short Form 36 (SF‐36) andEuroQol 5D were reported as secondary outcomes. However, no results were given for these outcomes in the published abstract report. </p> </section> <section id="CD011577-sec-0076"> <h5 class="title">Non‐fatal serious adverse events classified as:</h5> <section id="CD011577-sec-0077"> <h6 class="title">Serious bleeding (e.g. WHO / CTCAE grade 3 or above or equivalent)</h6> <p>No studies reported this outcome.</p> </section> <section id="CD011577-sec-0078"> <h6 class="title">Adverse transfusion reactions (including, but not limited to transfusion‐related acute lung injury (TRALI), transfusion‐associated circulatory overload (TACO), ABO mismatched transfusions and transfusion transmitted infection (TTI)) </h6> <p>No studies reported this outcome.</p> </section> <section id="CD011577-sec-0079"> <h6 class="title">Iron overload (defined by ferritin &gt; 1000 or clinical symptoms, or signs of iron overload, or all three) </h6> <p>No studies reported this outcome.</p> </section> <section id="CD011577-sec-0080"> <h6 class="title">Serious infections (infections requiring admission to hospital)</h6> <p>No studies reported this outcome.</p> </section> </section> <section id="CD011577-sec-0081"> <h5 class="title">Blood product requirement</h5> <section id="CD011577-sec-0082"> <h6 class="title">Red blood cell transfusion requirements (for example, number of units required or number of transfusion episodes) and intervals </h6> <p>In the <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> study there was insufficient evidence to determine a difference in the amount of red blood cell transfusions (1.8 units per patient per month in the liberal group, compared to 0.8 in the restrictive arm, no standard deviation was reported; very low quality evidence). </p> </section> <section id="CD011577-sec-0083"> <h6 class="title">Platelet transfusion requirements (for example, number of pools required, or number of transfusion episodes) and intervals </h6> <p>No studies reported this outcome.</p> </section> </section> <section id="CD011577-sec-0084"> <h5 class="title">Usage of iron chelation therapy</h5> <p>No studies reported this outcome.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011577-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011577-sec-0085"></div> <section id="CD011577-sec-0086"> <h3 class="title" id="CD011577-sec-0086">Summary of main results</h3> <p>A total of four RCTs met the inclusion criteria, however three studies (<a href="./references#CD011577-bbs2-0016" title="ISRCTN26088319 . Red cell transfusion and QOL in myelodysplastic syndromes. ISRCTN Registry2014. ">ISRCTN26088319</a> , <a href="./references#CD011577-bbs2-0017" title="NCT02099669 . Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC). CinicalTrials.gov2014. ">NCT02099669</a> , <a href="./references#CD011577-bbs2-0018" title="NTR2684 . Transfusion as supportive care for the improvement of quality of life. Netherlands Trial Register2011. ">NTR2684</a>) are ongoing, with only one study (<a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a>) being completed. This study randomised a total of 13 patients with MDS to a liberal or restrictive transfusion strategy. There was insufficient evidence to determine a difference in all‐cause mortality (RR 0.13, 95% CI 0.01 to 2.32). There was insufficient evidence to determine a difference in the number of red blood cell transfusions. No anaemia‐related complications were reported. No studies reported on mortality secondary to bleeding, infection, transfusion reactions or iron overload; quality of life; frequency and length of hospital admissions; serious infections (requiring admission to hospital); or serious bleeding (e.g. WHO/CTCAE grade 3 (or equivalent) or above). </p> </section> <section id="CD011577-sec-0087"> <h3 class="title" id="CD011577-sec-0087">Overall completeness and applicability of evidence</h3> <p>Conclusions drawn using the data extracted from this systematic review are very limited by the inclusion of only one RCT (<a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a>) with a small number of participants. The <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> study reported on only one of this review's primary outcomes, all‐cause mortality, and on one secondary outcome, red blood cell transfusion requirements. Due to the small numbers of participants in this study, there is insufficient evidence at present to draw any firm conclusions. The <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> study did not report on several of this review's outcomes, including mortality due to bleeding, infection, transfusion reactions, or iron overload, or both; frequency and length of hospital admissions; frequency and length of intensive care admission; serious bleeding; adverse transfusion reactions; iron overload; serious infections; platelet transfusion requirements; and usage of iron chelation therapy. This highlights the ongoing lack of data for these outcomes. Nevertheless, we identified three ongoing studies ( <a href="./references#CD011577-bbs2-0016" title="ISRCTN26088319 . Red cell transfusion and QOL in myelodysplastic syndromes. ISRCTN Registry2014. ">ISRCTN26088319</a>, <a href="./references#CD011577-bbs2-0017" title="NCT02099669 . Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC). CinicalTrials.gov2014. ">NCT02099669</a>, <a href="./references#CD011577-bbs2-0018" title="NTR2684 . Transfusion as supportive care for the improvement of quality of life. Netherlands Trial Register2011. ">NTR2684</a>) randomising participants to either a liberal or restrictive transfusion strategy with aims to measure many of the above outcomes. When complete, the results of all four RCTs taken together should provide more meaningful conclusions. These ongoing studies plan to complete recruitment by December 2016. </p> </section> <section id="CD011577-sec-0088"> <h3 class="title" id="CD011577-sec-0088">Quality of the evidence</h3> <p>The <a href="./references#CD011577-bbs2-0001" title="Transfusion Effects in Myelodysplastic Patients: Limiting Exposure. Smart Patients issue https://www.smartpatients.com/ accessed 14/10/2014. ISRCTN43616311 . Transfusion effects of myelodysplastic patients: limiting exposure. ISRCTN Register2005. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. The Haematology Jounal2004;5:S253. JansenAJG , BoschJ , HopWCJ , BeckersEAM , SchipperusMR , RhenenDJ . Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis2005;89:119. JansenAJG , Essink‐BotML , HopWCJ , BeckersEAM , RhenenDJ . Transfusion Policy and quality of life [Transfusiebeleid en kwaliteit van leven]. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde2003;28:280‐284. ">Temple 2004</a> study was published only in abstract form, and assessment of selection bias was not possible due to lack of information. With regards to blinding, the risk of bias here is unclear, as although the participants were blinded to their haemoglobin result, the method and assessment of blinding was not reported. Blinding of clinical staff to the intervention was also not reported. There was high attrition bias as it was not clear if and how the patients were lost to follow up (two deaths in the liberal group and one patient withdrew consent in the restrictive arm) however follow‐up was much shorter than planned (mean 6.2 to 7.4 months versus planned 15 months). Reporting bias risk was high due to a number of both primary and secondary outcomes not reported, despite intention to collect, as detailed in the trial registration. Finally, other risks of bias include the trial stopping earlier than planned due to poor recruitment, and a discrepancy noted between two published versions of the study abstract with regards to the dates reported for the recruitment timeline. It is not clear which is the correct recruitment time period. Overall, taking the above into account, high risk of bias exists for this study, and the quality of evidence is therefore very low. </p> <p>Overall the quality of the evidence was rated as very low across different outcomes according to GRADE methodology (<a href="./references#CD011577-bbs2-0057" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>) (<a href="./full#CD011577-tbl-0001">summary of findings Table for the main comparison</a>). This was due to the study being at high risk of bias, and the outcome estimates being imprecise. </p> <p>Two outcomes were considered very low grade quality evidence according to GRADE methodology due to the very serious risk of bias of the included studies (see above) and the serious imprecision of the estimates. </p> <p> <ul id="CD011577-list-0032"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Red blood cell transfusion requirements.</p> </li> </ul> </p> <p>The reason for the imprecision is because of the small number of participants within the trial and the low number of events. </p> <p>None of the other outcomes of this review were reported.</p> </section> <section id="CD011577-sec-0089"> <h3 class="title" id="CD011577-sec-0089">Potential biases in the review process</h3> <p>To our knowledge, our review process is free from bias. We conducted a comprehensive search; searching data sources (including multiple databases, and clinical trial registries) to ensure that all relevant trials would be captured. There were no restrictions made for the language in which the paper was originally published. The relevance of each paper identified was carefully assessed and all screening and data extractions were performed in duplicate. </p> <p>We pre‐specified all outcomes and subgroups prior to analysis.</p> <p>Only one study was included in this review so no meta‐analyses could be performed, and publication bias by the use of a funnel plot could not be performed. </p> </section> <section id="CD011577-sec-0090"> <h3 class="title" id="CD011577-sec-0090">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, there are no other systematic reviews that report on this topic. None of the systematic reviews excluded within this review (<a href="./references#CD011577-bbs2-0005" title="BreretonN , NicklassonL , MuftiG . UK estimates of the burden of disease associated with management of Intermediate‐2 or high‐risk myelodysplastic syndromes. Blood (ASH Annual Meeting Abstracts)2011;118:Abstract 4749. ">Brereton 2011</a>; <a href="./references#CD011577-bbs2-0006" title="CaocciG , EfficaceF , VignettiM , MandelliF , FaziP , LeddaA , et al. Health‐related quality of life of patients with myelodysplastic syndromes ‐ a systematic review from 1980 to 2008. Haematologica (42nd congress of the Italian Society of Haematology, Milan, Italy)2009;94 (s4):111. ">Caocci 2009</a>; <a href="./references#CD011577-bbs2-0008" title="ClissaC , FinelliC , VivoA . The myelodysplastic syndromes: diagnosis, prognosis and therapy. Italian Journal of Medicine2011;5:90‐97. ">Clissa 2011</a>; <a href="./references#CD011577-bbs2-0012" title="PinchonD , StanworthS , DoreeC , BrunskillS , NorfolkD . Quality of life and use of red cell transfusions in patients with myelodysplastic syndromes. A systematic review. American Journal of Haematology2009;84:671‐677. ">Pinchon 2009</a>; <a href="./references#CD011577-bbs2-0013" title="PlatzbeckerU , HofbauerL , EhningerG , HoligK . The clinical, quality of life and economic consequences of chronic anaemia and transfusion support in patients with myelodysplastic syndromes. Leukaemia Research2012;36:525‐536. ">Platzbecker 2012</a>) included studies that compared a restrictive versus liberal red cell transfusion strategy. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011577-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/urn:x-wiley:14651858:media:CD011577:CD011577-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_t/tCD011577-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA Study flow diagram." data-id="CD011577-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011577-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/urn:x-wiley:14651858:media:CD011577:CD011577-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_t/tCD011577-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011577-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011577-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/urn:x-wiley:14651858:media:CD011577:CD011577-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_t/tCD011577-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Liberal versus restrictive, outcome: 1.1 All cause mortality." data-id="CD011577-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Liberal versus restrictive, outcome: 1.1 All cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011577-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/urn:x-wiley:14651858:media:CD011577:CD011577-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_t/tCD011577-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Liberal versus restrictive, Outcome 1 All cause mortality." data-id="CD011577-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Liberal versus restrictive, Outcome 1 All cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/references#CD011577-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/media/CDSR/CD011577/image_n/nCD011577-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011577-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Restrictive red blood cell transfusion compared with liberal red blood cell transfusion for patients with myelodysplastic syndrome </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with myelodysplastic syndrome </p> <p><b>Settings</b>: 2 General and 1 University Hospital </p> <p><b>Intervention:</b> Restrictive red blood cell transfusion policy (Hb trigger &lt; 72 g/L) </p> <p><b>Comparison:</b> Liberal red blood cell transfusion policy (Hb trigger &lt; 96 g/L) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>[Liberal]</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>[Restrictive]</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><b>All cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Low risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p><b>RR 0.13</b> (0.01 to 2.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>13<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b> <br/> (1 to 162) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> <br/> (2 to 348) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>260 per 1000<sup>3</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> <br/> (3 to 603) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mortality secondary to bleeding/infection/transfusion reactions or iron overload</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Frequency and length of hospital admissions</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious infections (requiring admission to hospital)</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious bleeding (e.g. WHO/CTCAE grade 3 (or equivalent) or above )</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Red blood cell transfusion requirements</b> </p> <p>(units of red blood cells per patient per month)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The study reported a lower total transfused red cell amount in the restrictive versus liberal arm (0.8 units red cells per patient per month versus 1.8 units per patient per month). </p> <p>No statistical analysis of significance or further information was available from the study authors. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 for imprecision, very small study with only 13 participants. </p> <p><sup>2</sup>Downgraded by 2 for risk of bias due to reporting bias, attrition bias, and other bias. </p> <p><sup>3</sup>The mortality data was based on data derived from a Kaplan Meier plot for the IPSS‐R low, intermediate and high risk groups. Using information at one year from diagnosis (<a href="./references#CD011577-bbs2-0026" title="deSwartL , SmithA , JohnstonTW , HaaseD , DrosteJ , FenauxP , et al. Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry. British Journal of Haematology2015;[ahead of print online publication]:doi: 10.1111/bjh.13450. ">de Swart 2015</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/full#CD011577-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011577-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Liberal versus restrictive</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Liberal versus restrictive</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011577.pub2/references#CD011577-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011577.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011577-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011577-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD011577-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011577\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011577\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011577\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011577\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011577\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=fw9sVDQH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011577.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011577.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011577.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011577.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011577.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725807188"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011577.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725807191"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011577.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e84420a25936d',t:'MTc0MDcyNTgwNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 